MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00405-022-07586-2

Медицинская библиотека · European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2022

Evaluation of the relationship between prestin serum biomarker and sensorineural hearing loss: a case-control study.

Asli Rastin Hosseinzadeh, Akbarpour Maliheh, Lahiji Mahtab Raji, Leyli Ehsan Kazemnezhad, Pastadast Masoume, Ramezani Hedieh, Nemati Shadman

СтатьяПеревод пока не подготовлен

Аннотация

RESEARCH BACKGROUND AND AIM: There is not any routine serum biomarker for diagnosing hearing loss (HL). An inner ear-specific protein, prestin can be measured as a serum biochemical marker for HL diagnosis. The present study investigates, for the first time, the relationship between prestin serum levels and sensorineural HL (SNHL) in an Iranian population.

MATERIALS AND

METHODS

In this case-control study, 176 samples were examined in four groups including two control and two SNHL groups of 20-50 and ≥ 50 years with different severities of SNHL. Plasma prestin concentration was measured using Human Prestin (SLC26A5) ELISA Kit. Data analysis was conducted using SPSS v.23 with level of significance as 0.05.

RESULTS

Groups with SNHL had higher prestin levels (Mean = 182.29, SD = 71.24) compared to the control groups (Mean = 122.50, SD = 57.1) (P < 0.001). Results of the multinomial logistic regression of relationship between prestin level and SNHL remained significant after controlling intervening variables (P < 0.001 and odds ratio = 1.017 and 95% CI OR: 1.01-1.024). Results of the ordinal logistic regression model revealed that prestin level was significantly associated with the degree of HL (P < 0.001 and Odds ratio = 1.009 and 95% CI and OR: 1.005-1.013), so that the likelihood of HL increased with the rise in prestin levels. The best cutoff point for the 20-50 group was the prestin content of 132.5 pg/ml (sensitivity: 75%, specificity: 70.05%), while for the group of ≥ 50 was as 130 pg/ml (sensitivity: 84.1%, specificity: 68.2%).

CONCLUSIONS

Results of the present study revealed that prestin acts as a valuable biomarker for SNHL.

Для цитирования: Asli Rastin Hosseinzadeh, Akbarpour Maliheh, Lahiji Mahtab Raji, Leyli Ehsan Kazemnezhad, Pastadast Masoume, Ramezani Hedieh, Nemati Shadman. Evaluation of the relationship between prestin serum biomarker and sensorineural hearing loss: a case-control study.. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. 2022. DOI: 10.1007/s00405-022-07586-2.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.